Wangde Dai1, Sharon Hale2, Robert A Kloner3. 1. HMRI Cardiovascular Research Institute, Huntington Medical Research Institutes, 10 Pico Street, Pasadena, CA 91105, United States; Division of Cardiovascular Medicine of the Keck School of Medicine, University of Southern California, Los Angeles, CA 90017-2395, United States. Electronic address: wangdedai@yahoo.com. 2. HMRI Cardiovascular Research Institute, Huntington Medical Research Institutes, 10 Pico Street, Pasadena, CA 91105, United States. 3. HMRI Cardiovascular Research Institute, Huntington Medical Research Institutes, 10 Pico Street, Pasadena, CA 91105, United States; Division of Cardiovascular Medicine of the Keck School of Medicine, University of Southern California, Los Angeles, CA 90017-2395, United States.
Abstract
BACKGROUND: Adjunctive therapies, given in addition to reperfusion to reduce myocardial infarct size, have been disappointing based on clinical trials. New therapeutic targets independent of infarct size modification are needed. The no-reflow phenomenon occurs commonly after the infarct-related coronary artery is opened and predicts poor clinical outcome. We investigated the effects of a single application of delayed (post-reperfusion) therapeutic hypothermia (TH) in a rat model of coronary artery occlusion/reperfusion. METHODS: Rats were subjected to 60min of coronary artery occlusion followed by 3h of reperfusion. Rats were divided into normothermic (n=5) and TH (n=5) groups. In the TH, hypothermia was initiated at 1min after coronary artery reperfusion by pumping room-temperature (22°C) saline into and out of the thoracic cavity for 1h. This decreased intrathoracic temperature to around 26°C within 12min. At 3h after reperfusion, hearts were excised for infarct size and no-reflow zone measurement. RESULTS: Ischemic risk area and infarct size were similar between the 2 groups. No-reflow area (expressed as % of risk area) was significantly reduced in TH group (18.0±4.4%) compared with normothermic group (39.5±2.9%,P=0.005). When expressed as % of necrotic area, no-reflow area was reduced by more than half in TH group (25.5±6.4%) versus innormothermic group (54.4±5.3%,P=0.01). CONCLUSIONS: In this preliminary study, hypothermia initiated after reperfusion following 60min of coronary artery occlusion had no effect on infarct size yet substantially reduced the extent of no-reflow.
BACKGROUND: Adjunctive therapies, given in addition to reperfusion to reduce myocardial infarct size, have been disappointing based on clinical trials. New therapeutic targets independent of infarct size modification are needed. The no-reflow phenomenon occurs commonly after the infarct-related coronary artery is opened and predicts poor clinical outcome. We investigated the effects of a single application of delayed (post-reperfusion) therapeutic hypothermia (TH) in a rat model of coronary artery occlusion/reperfusion. METHODS:Rats were subjected to 60min of coronary artery occlusion followed by 3h of reperfusion. Rats were divided into normothermic (n=5) and TH (n=5) groups. In the TH, hypothermia was initiated at 1min after coronary artery reperfusion by pumping room-temperature (22°C) saline into and out of the thoracic cavity for 1h. This decreased intrathoracic temperature to around 26°C within 12min. At 3h after reperfusion, hearts were excised for infarct size and no-reflow zone measurement. RESULTS: Ischemic risk area and infarct size were similar between the 2 groups. No-reflow area (expressed as % of risk area) was significantly reduced in TH group (18.0±4.4%) compared with normothermic group (39.5±2.9%,P=0.005). When expressed as % of necrotic area, no-reflow area was reduced by more than half in TH group (25.5±6.4%) versus innormothermic group (54.4±5.3%,P=0.01). CONCLUSIONS: In this preliminary study, hypothermia initiated after reperfusion following 60min of coronary artery occlusion had no effect on infarct size yet substantially reduced the extent of no-reflow.
Authors: M Kohlhauer; V R Pell; N Burger; A M Spiroski; A Gruszczyk; J F Mulvey; Amin Mottahedin; A S H Costa; C Frezza; B Ghaleh; M P Murphy; R Tissier; T Krieg Journal: Basic Res Cardiol Date: 2019-03-15 Impact factor: 17.165
Authors: Juliana de F Germano; Chengqun Huang; Jon Sin; Yang Song; Kyle C Tucker; David J R Taylor; Hannaneh Saadaeijahromi; Aleksandr Stotland; Honit Piplani; Roberta A Gottlieb; Robert M Mentzer; Allen M Andres Journal: Sci Rep Date: 2020-05-19 Impact factor: 4.379
Authors: Yang Song; Chengqun Huang; Jon Sin; Juliana de F Germano; David J R Taylor; Reetu Thakur; Roberta A Gottlieb; Robert M Mentzer; Allen M Andres Journal: Int J Mol Sci Date: 2021-12-31 Impact factor: 5.923
Authors: Mohamed El Farissi; Thomas P Mast; Mileen R D van de Kar; Daimy M M Dillen; Jesse P A Demandt; Fabienne E Vervaat; Rob Eerdekens; Simon A G Dello; Danielle C Keulards; Jo M Zelis; Marcel van 't Veer; Frederik M Zimmermann; Nico H J Pijls; Luuk C Otterspoor Journal: J Clin Med Date: 2022-02-18 Impact factor: 4.241